Singapore markets closed

Molecular Templates, Inc. (MTEM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.2200-0.0800 (-1.86%)
At close: 1:00PM EST
4.2900 +0.07 (+1.66%)
After hours: 04:34PM EST
Sign in to post a message.
  • J
    John
    Ask yourself one question. Why is it that this company, after 21 year of being in business, not restricted financially, was not able to advance a single product beyond phase 1 trials? There is no simple answer to that, but typically it is a combination of unvalidated scientific idea, the drug is not developable, the team is not qualified or takes a wrong approach. This company keeps growing and spending more and more of the investor's money without any tangible progress. Sounds like one last desperate dash before the total collapse.
  • T
    Tom
    Looking for more good news to drive this down further. Doubled my holdings in 4s, and will buy more in 3s. Is this a fun stock or what?
  • N
    Nick
    Am I missing something or did FDA grant Fast Track for MTEM? Who would be selling now?
  • R
    Richard
    Selling continues without relenting pushing it to almost all time low daily. What I’d going on with this one biotech.
    Very disappointed and frustrated as a shareholder. May be this is the yearend selloff to harvest the loss many had gained this year?
  • T
    Tom
    For what its worth, and while MTEM is a particularly egregious example, every clinical stage biopharma I own has been tanking recently. No apparent reason except each one depends on the catalyst of successful clinical trials. You gotta believe Wendy.
  • J
    J
    Been a very quite message board and for good reason. Stock has been a dog. The 10 percent owner who owns closer to 20 percent as thrown away so many millions. My guess is at some point they throw in the towel. If that happens we have a 3 dollar stock folks.
  • Y
    Yahoo Finance Insights
    Molecular Templates reached a 52 Week low at 4.05
  • T
    Tom
    While I'm in this for the long haul, seems to go up and down day to day like a yoyo. Physics explains yoyos, but the only reason I can see for stock's gyrations is low volume daily transactions.
  • R
    Richard
    May be this biotech Target fund does have some good reading on this one finally. It was buying merely three days ago and added 100,000 shares at $6. Today it has gone up almost a bucks now at $7.58! This is whopping over 25% over the price it had added. Love to see such a move without news which means something big is behind the scene ready to be disclosed! It is still a little over 50% below its high of the year, so we have plenty to go up!
  • A
    AC
    Ten percent owner bought more: 100000 shares @6.13 a share.
  • R
    Richard
    This stock acts in such an unfathomable manner as defying logic. Even in a super strong market like today when DOW up over 500 points and practically 90% of the stocks go up like even GE up over $5. This one is down over 6%! Yes at the same time, that biotech fund continues its buying spree on this one now exceeding 10 millions shares as its position. Does this fund knows something we don’t and why this stock continues to go down?
  • A
    AC
    Why is it sinking?
  • k
    kitty
    up today
  • Y
    Yahoo Finance Insights
    Molecular Templates reached a 52 Week low at 4.31
  • Y
    Yahoo Finance Insights
    Molecular Templates reached a 52 Week low at 4.65
  • Y
    Yahoo Finance Insights
    Molecular Templates reached a 52 Week low at 4.11
  • Y
    Yahoo Finance Insights
    Molecular Templates reached a 52 Week low at 4.75
  • J
    Jack
    10% Owner has bought 850,000 shares in the last week ($5.4 million). Reported EPS for Q2 is $-0.28. Chart pattern is currently a falling wedge, with a resistance ~$6.15.

    It's the perfect setup for a trend reversal, but the question to be asked is: "When?" Until MTEM's next earnings date (Nov. 04?), or some form of new information, I suspect MTEM will continue to go down.

    Never buy a stock solely based on insider trading; wait for more information to come out.
  • Y
    Yahoo Finance Insights
    Molecular Templates is down 7.43% to 4.98
  • R
    Richard
    Four times the usual volume already so far. Is Biotech Target fund buying again after accumulating 850,000 more shares in the previous four days.